Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) just unveiled an update.
GlaxoSmithKline Pharmaceuticals Limited has notified the stock exchanges that it has published newspaper advertisements regarding a postal ballot notice, in compliance with Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015. The move reflects the company’s ongoing adherence to corporate governance and disclosure norms as it seeks shareholder approval on matters placed through the postal ballot process, underscoring its commitment to regulatory transparency and investor communication.
More about GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is an India-based pharmaceutical company focused on the research, development, manufacturing and marketing of prescription medicines and vaccines. Operating as part of the global GSK group, it serves the domestic healthcare market with a portfolio spanning key therapeutic areas and branded pharmaceutical products.
Average Trading Volume: 4,635
Technical Sentiment Signal: Buy
Current Market Cap: 422.1B INR
For an in-depth examination of GLAXO stock, go to TipRanks’ Overview page.